Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  59 results for ""Receptor, EphA2""

Your Filters

Subject : neoplasms
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis.

  • Authors : Wang G; Department of Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.; Xiao H

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

  • Source: Medicine [Medicine (Baltimore)] 2024 Nov 29; Vol. 103 (48), pp. e40741.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

  • Authors : Toracchio L; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.; Carrabotta M

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 13; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

  • Authors : Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.; Sarah Cannon Research Institute, Nashville, TN.

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 10; Vol. 42 (29), pp. 3443-3452. Date of Electronic Publication: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present).

Subjects: Patents as Topic* ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/antagonists & inhibitors ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Oct; Vol. 34 (10), pp. 1009-1018. Date of Electronic Publication: 2024 Sep 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.

  • Authors : Li Y; Shenzhen Key Laboratory of Systems Medicine for inflammatory diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-sen University, Shenzhen, China.; Clinical Technology Laboratory, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/genetics ; Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/metabolism

  • Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2024 Aug; Vol. 51 (8), pp. e13902.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print Cited Medium: Internet ISSN: 1440-1681

Record details

Read More Add to Saved list
×
Academic Journal

Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.

  • Authors : Veiga RN; Laboratory of Human Cytogenetics and Oncogenetics, Postgraduate Program in Genetics. Department of Genetics, Universidade Federal Do Paraná, Rua Coronel Francisco Heráclito Dos Santos, 100, Jardim das AméricasCuritiba, CEP, 81531-980, Brazil.; de Azevedo ALK

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/metabolism ; Erythropoietin*

  • Source: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Apr; Vol. 102 (4), pp. 479-493. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer International Country of Publication: Germany NLM ID: 9504370 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment.

  • Authors : Nehal M; Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, 226026, India.; Khatoon J

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Molecular biology reports [Mol Biol Rep] 2024 Feb 23; Vol. 51 (1), pp. 337. Date of Electronic Publication: 2024 Feb 23.Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978

Record details

Read More Add to Saved list
×
Academic Journal

Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study.

  • Authors : Vincenzi M; Institute of Biostructures and Bioimaging, Via Pietro Castellino 111, 80131 Naples, Italy.; Mercurio FA

Subjects: Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/chemistry ; Neoplasms*; Sterile Alpha Motif

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Feb 27; Vol. 29 (5). Date of Electronic Publication: 2024 Feb 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy.

  • Authors : Yang Y; Public Center of Experimental Technology, the School of Basic Medical Science, Southwest Medical University, Luzhou, China.; Nian S

Subjects: Immunotherapy* ; Peptide Library*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacology

  • Source: Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (2), pp. 10379-10400.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101581063 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2.

  • Authors : Cui S; School of Life Science and Technology, State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, 150001, Heilongjiang, China.; Wu Q

Subjects: Enhancer Elements, Genetic* ; Gene Expression Regulation, Neoplastic*; Fos-Related Antigen-2/Fos-Related Antigen-2/Fos-Related Antigen-2/*genetics

  • Source: Cell death & disease [Cell Death Dis] 2021 Mar 12; Vol. 12 (3), pp. 264. Date of Electronic Publication: 2021 Mar 12.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  59 results for ""Receptor, EphA2""